Your browser doesn't support javascript.
loading
First-in-Class NADH/Ubiquinone Oxidoreductase Core Subunit S7 (NDUFS7) Antagonist for the Treatment of Pancreatic Cancer.
Xu, Yibin; Xue, Ding; Kyani, Armita; Bankhead, Armand; Roy, Joyeeta; Ljungman, Mats; Neamati, Nouri.
Affiliation
  • Xu Y; Department of Medicinal Chemistry, College of Pharmacy, University of Michigan, Ann Arbor, Michigan 48109, United States.
  • Xue D; Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan 48109, United States.
  • Kyani A; Department of Medicinal Chemistry, College of Pharmacy, University of Michigan, Ann Arbor, Michigan 48109, United States.
  • Bankhead A; Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan 48109, United States.
  • Roy J; Department of Medicinal Chemistry, College of Pharmacy, University of Michigan, Ann Arbor, Michigan 48109, United States.
  • Ljungman M; Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan 48109, United States.
  • Neamati N; Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan 48109, United States.
ACS Pharmacol Transl Sci ; 6(8): 1164-1181, 2023 Aug 11.
Article in En | MEDLINE | ID: mdl-37588763
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: ACS Pharmacol Transl Sci Year: 2023 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: ACS Pharmacol Transl Sci Year: 2023 Type: Article Affiliation country: United States